1574541-75-5

Upstream product

• 701-45-1 2-bromo-1-fluoro-4-nitrobenzene 
• 123-75-1 pyrrolidine 
• 14150-94-8 3,5-dinitro-1-methyl-2-pyridone 
• 107-87-9 2-Pentanone 
• 97-94-9 triethyl borane 
• 1260655-13-7 1-(2-bromo-4-nitrophenyl)pyrrolidine 

Downstream Products

• 1574541-76-6 3-ethyl-4-(pyrrolidin-1-yl)aniline 
• 1574538-38-7 3-(4-cyclopropylphenoxy)-1-(3-ethyl-4-(pyrrolidin-1-yl)phenyl)pyrrolidin-2-one 
• 1574538-39-8 3-(4-cyclopropylphenoxy)-1-(3-ethyl-4-(pyrrolidin-1-yl)phenyl)pyrrolidin-2-one 
• 1574538-40-1 3-(4-cyclopropylphenoxy)-1-(3-ethyl-4-(pyrrolidin-1-yl)phenyl)pyrrolidin-2-one 

Relevant academic research and scientific papers

Tailor-made synthesis of N,N,2,6-tetrasubstituted 4-nitroanilines by three-component ring transformation of dinitropyridone

The ring transformation of dinitropyridone afforded various kinds of 2,6-disubstituted-4-nitroanilines upon treatment with aliphatic ketones in the presence of ammonium acetate as a nitrogen source, wherein dinitropyridone behaved as the synthetic equival

PYRROLONE OR PYRROLIDINONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS

The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are melanin concentrating hormone receptor-1 (MCHR1) antagonists which may be used as medicaments.